FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3160831353> ?p ?o ?g. }

• W3160831353 abstract "Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) share a target receptor with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The use of ACEIs/ARBs may cause angiotensin-converting enzyme 2 receptor upregulation, facilitating the entry of SARS-CoV-2 into host cells. There is concern that the use of ACEIs/ARBs could increase the risks of severe COVID-19 and mortality. The impact of discontinuing these drugs in patients with COVID-19 remains uncertain. We aimed to assess the association between the use of ACEIs/ARBs and the risks of mortality and severe disease in patients with COVID-19. A systematic search was performed in PubMed, EMBASE, Cochrane Library, and MedRxiv.org from December 1, 2019, to June 20, 2020. We also identified additional citations by manually searching the reference lists of eligible articles. Forty-two observational studies including 63,893 participants were included. We found that the use of ACEIs/ARBs was not significantly associated with a reduction in the relative risk of all-cause mortality [odds ratio (OR) = 0.87, 95% confidence interval (95% CI) = 0.75–1.00; I 2 = 57%, p = 0.05]. We found no significant reduction in the risk of severe disease in the ACEI subgroup (OR = 0.95, 95% CI = 0.88–1.02, I 2 = 50%, p = 0.18), the ARB subgroup (OR = 1.03, 95% CI = 0.94–1.13, I 2 = 62%, p = 0.48), or the ACEI/ARB subgroup (OR = 0.83, 95% CI = 0.65–1.08, I 2 = 67%, p = 0.16). Moreover, seven studies showed no significant difference in the duration of hospitalization between the two groups (mean difference = 0.33, 95% CI = −1.75 to 2.40, p = 0.76). In conclusion, the use of ACEIs/ARBs appears to not have a significant effect on mortality, disease severity, or duration of hospitalization in COVID-19 patients. On the basis of the findings of this meta-analysis, there is no support for the cessation of treatment with ACEIs or ARBs in patients with COVID-19." @default.
• W3160831353 created "2021-05-24" @default.
• W3160831353 creator A5017001819 @default.
• W3160831353 creator A5047736308 @default.
• W3160831353 creator A5070473742 @default.
• W3160831353 creator A5071362089 @default.
• W3160831353 creator A5075677631 @default.
• W3160831353 date "2021-04-26" @default.
• W3160831353 modified "2023-09-27" @default.
• W3160831353 title "Associations Between the Use of Renin–Angiotensin System Inhibitors and the Risks of Severe COVID-19 and Mortality in COVID-19 Patients With Hypertension: A Meta-Analysis of Observational Studies" @default.
• W3160831353 cites W1617328014 @default.
• W3160831353 cites W2126930838 @default.
• W3160831353 cites W3004348779 @default.
• W3160831353 cites W3009335299 @default.
• W3160831353 cites W3009912996 @default.
• W3160831353 cites W3009941720 @default.
• W3160831353 cites W3012285389 @default.
• W3160831353 cites W3013231340 @default.
• W3160831353 cites W3013302817 @default.
• W3160831353 cites W3013564424 @default.
• W3160831353 cites W3013824443 @default.
• W3160831353 cites W3013871850 @default.
• W3160831353 cites W3013921190 @default.
• W3160831353 cites W3014797709 @default.
• W3160831353 cites W3014972079 @default.
• W3160831353 cites W3015407900 @default.
• W3160831353 cites W3015824279 @default.
• W3160831353 cites W3016059785 @default.
• W3160831353 cites W3016259848 @default.
• W3160831353 cites W3016358278 @default.
• W3160831353 cites W3016535995 @default.
• W3160831353 cites W3016553045 @default.
• W3160831353 cites W3016944852 @default.
• W3160831353 cites W3017545174 @default.
• W3160831353 cites W3019844653 @default.
• W3160831353 cites W3019849260 @default.
• W3160831353 cites W3019906742 @default.
• W3160831353 cites W3021366174 @default.
• W3160831353 cites W3021992825 @default.
• W3160831353 cites W3022580747 @default.
• W3160831353 cites W3023640683 @default.
• W3160831353 cites W3023670326 @default.
• W3160831353 cites W3023751598 @default.
• W3160831353 cites W3024432354 @default.
• W3160831353 cites W3024575398 @default.
• W3160831353 cites W3025214947 @default.
• W3160831353 cites W3025304547 @default.
• W3160831353 cites W3025598899 @default.
• W3160831353 cites W3025732321 @default.
• W3160831353 cites W3026300204 @default.
• W3160831353 cites W3028492182 @default.
• W3160831353 cites W3028967077 @default.
• W3160831353 cites W3030177929 @default.
• W3160831353 cites W3030868216 @default.
• W3160831353 cites W3032939692 @default.
• W3160831353 cites W3033315848 @default.
• W3160831353 cites W3034567463 @default.
• W3160831353 cites W3034872024 @default.
• W3160831353 cites W3035752400 @default.
• W3160831353 cites W3035790792 @default.
• W3160831353 cites W3035819488 @default.
• W3160831353 cites W3036500066 @default.
• W3160831353 cites W3037521489 @default.
• W3160831353 cites W3048086118 @default.
• W3160831353 cites W3048523835 @default.
• W3160831353 cites W3080783441 @default.
• W3160831353 cites W3081277611 @default.
• W3160831353 cites W3122900688 @default.
• W3160831353 cites W3128267370 @default.
• W3160831353 cites W3132423433 @default.
• W3160831353 cites W3134804907 @default.
• W3160831353 cites W3138686467 @default.
• W3160831353 cites W3185026945 @default.
• W3160831353 cites W4205912111 @default.
• W3160831353 doi "https://doi.org/10.3389/fcvm.2021.609857" @default.
• W3160831353 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8107232" @default.
• W3160831353 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33981731" @default.
• W3160831353 hasPublicationYear "2021" @default.
• W3160831353 type Work @default.
• W3160831353 sameAs 3160831353 @default.
• W3160831353 citedByCount "11" @default.
• W3160831353 countsByYear W31608313532021 @default.
• W3160831353 countsByYear W31608313532022 @default.
• W3160831353 countsByYear W31608313532023 @default.
• W3160831353 crossrefType "journal-article" @default.
• W3160831353 hasAuthorship W3160831353A5017001819 @default.
• W3160831353 hasAuthorship W3160831353A5047736308 @default.
• W3160831353 hasAuthorship W3160831353A5070473742 @default.
• W3160831353 hasAuthorship W3160831353A5071362089 @default.
• W3160831353 hasAuthorship W3160831353A5075677631 @default.
• W3160831353 hasBestOaLocation W31608313531 @default.
• W3160831353 hasConcept C126322002 @default.
• W3160831353 hasConcept C156957248 @default.
• W3160831353 hasConcept C187960798 @default.
• W3160831353 hasConcept C23131810 @default.
• W3160831353 hasConcept C2776478404 @default.
• W3160831353 hasConcept C2779134260 @default.
• W3160831353 hasConcept C3008058167 @default.
• W3160831353 hasConcept C44249647 @default.
• W3160831353 hasConcept C524204448 @default.

• next